{
  "cik": 1867096,
  "cik_padded": "0001867096",
  "entityName": "Xeris Biopharma Holdings, Inc.",
  "fiscal_years": [
    {
      "accn": "0001867096-26-000016",
      "filed": "2026-03-02",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 111042000.0,
        "eps_diluted": 0.0,
        "net_income": 554000.0,
        "operating_cash_flow": 28626000.0,
        "operating_income": 24896000.0,
        "revenue": 291845000.0,
        "stockholders_equity": 13689000.0,
        "total_assets": 383527000.0,
        "total_liabilities": 369838000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 27.01716706844912,
        "net_margin": 0.0018982679161883874,
        "operating_margin": 0.08530555603145505,
        "revenue_growth_yoy": 0.43716452454818533,
        "roa_avg2y": 0.0015681013095344238,
        "roa_period_end": 0.001444487611041726,
        "roe_avg2y": -0.06957176943363054,
        "roe_period_end": 0.040470450726860986
      }
    },
    {
      "accn": "0001867096-26-000016",
      "filed": "2026-03-02",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 71621000.0,
        "eps_diluted": -0.37,
        "net_income": -54836000.0,
        "operating_cash_flow": -36981000.0,
        "operating_income": -33646000.0,
        "revenue": 203070000.0,
        "stockholders_equity": -29615000.0,
        "total_assets": 323060000.0,
        "total_liabilities": 352675000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "net_margin": -0.27003496331314325,
        "operating_margin": -0.16568670901659527,
        "revenue_growth_yoy": 0.23888136461803142,
        "roa_avg2y": -0.1698597718310819,
        "roa_period_end": -0.1697393673001919,
        "roe_avg2y": 3.013215374893535
      }
    },
    {
      "accn": "0001867096-26-000016",
      "filed": "2026-03-02",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 67449000.0,
        "eps_diluted": -0.45,
        "net_income": -62255000.0,
        "operating_cash_flow": -47023000.0,
        "operating_income": -44010000.0,
        "revenue": 163914000.0,
        "stockholders_equity": -6782000.0,
        "total_assets": 322602000.0,
        "total_liabilities": 329384000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "net_margin": -0.3798028234317996,
        "operating_margin": -0.26849445440901937,
        "revenue_growth_yoy": 0.486775270299688,
        "roa_avg2y": -0.18663696704061014,
        "roa_period_end": -0.1929777248746133,
        "roe_avg2y": -3.2420257778935033
      }
    },
    {
      "accn": "0001867096-26-000016",
      "filed": "2026-03-02",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 121966000.0,
        "eps_diluted": -0.7,
        "net_income": -94660000.0,
        "operating_cash_flow": -102891000.0,
        "operating_income": -81940000.0,
        "revenue": 110248000.0,
        "stockholders_equity": 45187000.0,
        "total_assets": 344522000.0,
        "total_liabilities": 299335000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 6.624360988779959,
        "net_margin": -0.8586096799941949,
        "operating_margin": -0.7432334373412669,
        "revenue_growth_yoy": 1.2231901593063117,
        "roa_avg2y": -0.2917629218210371,
        "roa_period_end": -0.2747574900877157,
        "roe_avg2y": -1.3482601945619508,
        "roe_period_end": -2.094850288799876
      }
    },
    {
      "accn": "0001867096-25-000039",
      "filed": "2025-03-06",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 67271000.0,
        "eps_diluted": -1.55,
        "net_income": -122725000.0,
        "operating_cash_flow": -95535000.0,
        "operating_income": -115156000.0,
        "revenue": 49590000.0,
        "stockholders_equity": 95231000.0,
        "total_assets": 304361000.0,
        "total_liabilities": 209130000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 2.196028604131008,
        "revenue_growth_yoy": 1.460431654676259,
        "roa_avg2y": -0.5295440031757538,
        "roa_period_end": -0.40322183196927325,
        "roe_avg2y": -1.9028311833291986,
        "roe_period_end": -1.2887085087839043
      }
    },
    {
      "accn": "0001867096-24-000031",
      "filed": "2024-03-06",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 37598000.0,
        "net_income": -91140000.0,
        "operating_cash_flow": -80558000.0,
        "operating_income": -83546000.0,
        "revenue": 20155000.0,
        "stockholders_equity": 33761000.0,
        "total_assets": 159151000.0,
        "total_liabilities": 125390000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 3.714048754480021,
        "roa_period_end": -0.5726636967408311,
        "roe_avg2y": -3.7819781314189678,
        "roe_period_end": -2.699564586357039
      }
    },
    {
      "accn": "0001867096-22-000040",
      "filed": "2022-03-11",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "cash": 19519000.0,
        "stockholders_equity": 14436000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001867096-26-000016",
    "filed": "2026-03-02",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001867096.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001867096.json"
  },
  "ticker": "XERS"
}